CNAP vs IABP in Pregnant Women With Placenta Accreta

Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Dec 11, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a new way to monitor blood pressure during cesarean deliveries for pregnant women who may have a condition called placenta accreta. Placenta accreta occurs when the placenta grows too deeply into the uterine wall, which can cause serious complications. The researchers want to see if a method called Continuous Non-Invasive Arterial Pressure (CNAP) can provide accurate blood pressure readings that are similar to the standard method, Intra-Aortic Balloon Pump (IABP). They will also look at whether using CNAP can help doctors make better decisions during surgery.

To be eligible for this study, women must be between 18 and 40 years old and scheduled for an elective cesarean delivery due to placenta accreta. However, those with certain heart conditions, recent upper limb surgeries, or other specific health issues won't be able to participate. Participants can expect to have their blood pressure monitored using both CNAP and IABP during their procedure and will contribute to important research that may improve care for future patients facing similar situations.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 18-40 years old with pregnancy complicated by accreta spectrum undergoing elective, scheduled cesarean delivery and possible hysterectomy
• Exclusion Criteria:
• • Women aged \<18
• • Patients with cardiac arrhythmia
• • Vascular pathologies of the upper limbs (recent vascular surgery, Reynaud's disease, vascular stenosis)
• • Contraindication to neuraxial anesthesia
• • Emergent cases
• • Droplet or airborne precautions (as determined by BIDMC infection control policy)